Yotis A. Senis

Etablissement Français Du Sang Grand Est
Strasbourg, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

The mitochondrial deacetylase SIRT3 is nonessential for cyclophilin D-dependent procoagulant platelet formation in mice.

The mitochondrial deacetylase SIRT3 is nonessential for cyclophilin D-dependent procoagulant platelet formation in mice.

Journal: Platelets
Published: September 03, 2026

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Journal: Circulation research
Published: June 16, 2026

Synergistic effects of deleting the tyrosine phosphatases Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis in mice.

Synergistic effects of deleting the tyrosine phosphatases Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis in mice.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation.

Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation.

Journal: The Journal of clinical investigation
Published: May 28, 2025

European Research Council-funded grant: maintenance of platelet homeostasis.

European Research Council-funded grant: maintenance of platelet homeostasis.

Journal: European heart journal
Published: April 02, 2025

Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB-9778.

Targeting CD148 for Antithrombotic Therapy: Functional and Molecular Evaluation of AKB-9778.

Journal: Pharmacology research & perspectives
Published: March 05, 2025

Defining and Harnessing the Megakaryocyte/Platelet Checkpoint.

Defining and Harnessing the Megakaryocyte/Platelet Checkpoint.

Journal: Molecular and cellular biology
Published: February 24, 2025

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice.

Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice.

Journal: Blood advances
Published: January 03, 2025

Cooperative effect between anti-PF4/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HIT.

Cooperative effect between anti-PF4/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HIT.

Journal: Blood advances
Published: October 17, 2024

G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.

G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.

Journal: bioRxiv : the preprint server for biology
Published: May 27, 2024

LAIR-1 and PECAM-1 function via the same signaling pathway to inhibit GPVI-mediated platelet activation.

LAIR-1 and PECAM-1 function via the same signaling pathway to inhibit GPVI-mediated platelet activation.

Journal: Research and practice in thrombosis and haemostasis
Published: May 02, 2024

Mouse tissue factor enzyme-linked immunosorbent assays: a sensitive issue.

Mouse tissue factor enzyme-linked immunosorbent assays: a sensitive issue.

Journal: Research and practice in thrombosis and haemostasis
Published: February 15, 2024
Showing 1-12 of 54

Last Updated: 09/26/2026